0521779407-09 CUNY1086/Karliner 0 521 77940 7 June 4, 2007 21:12
Hepatic Veno-Occlusive Disease 681
■sudden weight gain >2% of baseline body weight
■total serum bilirubin >2.0 mg/dL
■may correlate with subsequent development of renal insufficiency,
pleural effusion, cardiac failure, pulmonary infiltrates, bleeding.
■chronic form: similar to those of chronic BCS
tests
Laboratory
■basic studies: nonspecific elevation of aminotransferases, alkaline
phosphatase bilirubin, prothrombin time
Imaging
■Doppler flow studies: usually normal
■ultrasound: signs of portal hypertension (splenomegaly, ascites)
■hepatic venous pressure (measured by transjugular approach): very
specific for VOD if >10 mmHg
Liver Biopsy
■histologic features:
■nonthrombotic obliteration of small intrahepatic veins
■concentric subendothelial thickening
■thrombosis secondary to sclerosis
■perivenular and sinusoidal fibrosis
■centrilobar hepatocyte necrosis
■no single histologic feature pathognomonic
differential diagnosis
■graft-versus-host disease: rarely occurs before day 15 post-BMT
■drug toxicity: rarely causes ascites and hepatomegaly
■sepsis
■post-transfusion hepatitis: usually occurs later in the course
management
What to Do First
■evaluate pulmonary status and possible need for ventilatory support
■assess patient’s fluid status, possible bleeding and infection
■recognition of possible multiple organ failure
General Measures
■diuresis for fluid overload, platelet and RBCs as necessary
■broad-spectrum antibiotics to treat presumptive infection